NCT06891573 South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
| NCT ID | NCT06891573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seong Hye Choi, MD |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-26 |
| Primary Completion | 2025-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-26 with a primary completion date of 2025-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility randomized controlled trial is to investigate the applicability of software that aims to improve symptoms of frailty by implementing customized interventions such as physical exercise and cognitive training implemented through a mobile app for 16 weeks for patients diagnosed with frailty or prefrailty. The primary outcomes are adherence, retention rates, and recruitment rates. Participants will participate in customized interventions including physical exercise, cognitive training, nutritional guidance, and management of disease related to frailty for 16 weeks.
Eligibility Criteria
Inclusion Criteria: * 60-90 years of age * Residing in the community * Total score of Modified Fried frailty phenotype score ≥ 1 point * Korean Mini-Mental State Examination-2 z-score ≥ -1.5 * Can read and write * Being able to use the a mobile app through education or having someone help a participant use the mobile app * Having a reliable informant who could provide investigators with the requested information. * written informed consent Exclusion Criteria: * Major psychiatric illness such as major depressive disorders * Dementia * Other neurodegenerative disease (e.g., Parkinson's disease) * Malignancy within five years * Cardiac stent or revascularization within one year * Serious or unstable symptomatic cardiovascular disease * Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease * Severe loss of vision, hearing, or communicative disability * Significant laboratory abnormality that may result in cognitive impairment * Any conditions preventing cooperation as judged by the study physician * Unable to participate in exercise program safely * Coincident participation in any other intervention trial
Contact & Investigator
Seong Hye Choi, MD, PhD
PRINCIPAL INVESTIGATOR
Inha University Hospital
Frequently Asked Questions
Who can join the NCT06891573 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 90 Years, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06891573 currently recruiting?
Yes, NCT06891573 is actively recruiting participants. Contact the research team at sseonghye@inha.ac.kr for enrollment information.
Where is the NCT06891573 trial being conducted?
This trial is being conducted at Incheon, South Korea, Seoul, South Korea, Suwon, South Korea.
Who is sponsoring the NCT06891573 clinical trial?
NCT06891573 is sponsored by Seong Hye Choi, MD. The principal investigator is Seong Hye Choi, MD, PhD at Inha University Hospital. The trial plans to enroll 40 participants.